×

product

Retatrutide

  • Purity (HPLC):98%
  • CAS:2381089-83-2
  • Molecular Formula:C221H342N46O68
  • Molecular Weight:4731.33

    Feature

    Retatrutide is a multi-receptor peptide agonist that activates GLP-1 receptors, GIP receptors, and glucagon receptors. It has beneficial effects on metabolism, appetite regulation, and energy expenditure.
    It is an experimental weight loss and antidiabetic drug ingredient. It is more effective than tirzepatide.

    FeatureRetatrutide
    TypeTriple agonist (GLP-1/GIP/glucagon)
    PurposeObesity, Type 2 diabetes
    StatusPhase 3 trials
    Weight Loss Effect~24% in trials (at high dose)

    Product name
    Retatrutide
    CAS NO2381089-83-2
    SequenceTyr- {Aib}-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile- {   α-Me-Leu}-Leu-Asp-Lys- {diacid-C20-gamma-Glu-(AEEA)-Lys}- Ala-Gln- {Aib}-Ala-Phe-Ile-Glu-Tyr-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro -Pro-Ser-NH2
    Molecular FormulaC221H342N46O68
    Molecular Weight4731.33
    Store atKeep in dark and cool dry place

    Specification-COA

    ItemsStandardsResults
    AppearanceWhite to off-white powderComplies
    Identity by MSTheoretical MW:4731.33Complies
    Purity (HPLC)Not less than 98.0%99.16%
    Sodium saltNot more than 5.0%0.61%
    Water Content (K.F)Not more than 7.0%3.58%
    Peptide ContentNot less than 85.0%Complies
    ConclusionConforms to standardComplies

    Function and Application

    GLP-1 reduces appetite, slows gastric emptying, and promotes insulin secretion.
    GIP may reduce food intake and promote insulin secretion.
    Glucagon increases energy expenditure.
    Therefore, Retatrutide can provide excellent weight loss and metabolic control effects.
    The ingredient is in clinical trials and has shown efficacy in both obesity and type 2 diabetes.

    Related Products

    View All